blue cross glp 1 coverage Ro launches GLP-1 insurance checker Digital health company Ro launches

GLP-1 receptor agonists, such as Wegovy, which contain the active ingredient semaglutide, are a class of medications widely used for obesity and type 2 diabetes

Ro is among the telehealth companies working to expedite that process by helping consumers find coverage options, treatment plans, and a provider that is right for their needs and goals

The fact that retatrutide passed its Phase 1 and Phase 2 trials means researchers deemed it safe enough for large-scale human testing

reported a three-fold higher risk of major depression, and a doubled risk for anxiety and suicidal behavior in a large ( n = 11,683,623) retrospective study of GLP-1RA users utilizing the TrinetX database (100)

demonstrates the ability of [dSer2]glucagon-CEX to stimulate a 100150% increase in acute insulin secretion relative to the non-CEX-extended glucagon in a GLP-1R-dependent manner, ultimately mitigating acute GcgR-induced glucose excursion [112]